Advertisment MEACR
Home Print this page Email this page Users Online: 84
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login
Current Issue

July-August 2016 | Vol 5 | Issue 4

RSS Feed for Current Issue RSS Feed for Current Issue

Original Article
A study of usefulness of washes and brush cytology with respect to histopathology in diagnosis of lung malignancy by using fiberoptic bronchoscopy
Background: Examination of specimens obtained through flexible fiberoptic bronchoscope is important and often the initial diagnostic technique performed in patients with suspected malignant l...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Primary intracranial germ cell tumors: A single institution experience from a South Indian tertiary cancer center
Background: Intracranial germ cell tumors (ICGCTs) are rare tumors seen in the pineal and suprasellar regions. The World Health Organization has classified ICGCTs into germinoma and nongermin...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Morphometric assessment of microvessel density in head and neck squamous cell carcinoma using immunomarker CD105 and its correlation with clinicopathological parameters
Background: Blood vessel counts using CD105 staining are more informative marker of prognosis as compared with staining by other endothelial markers. We conducted a study to compare intratumo...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Defining the T status in breast cancer: Where do we stand?
Background: Tumor size in breast cancer is a key factor for staging, prognosticating, and deciding the choice of treatment. Currently, there are no standard rules for measuring the T status i...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Case Report
Favorable response in “locally advanced stage” of adenocarcinoma lung to erlotinib: Quality of life and clinical and radiological outcome are satisfactory after 24 weeks
Lung cancer is one of the most common types of cancer and the leading cause of human cancer deaths worldwide. Adenocarcinoma is the most common histological type of lung cancer. Tyrosine kinase inhi...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris Primo Central, Google Scholar, Hinari, Infotrieve, Journal Guide, National Science Library, OpenJGate, ProQuest, TdNet

The journal is indexed with, or included in, the following:
DOAJ, Emerging Sources Citation Index, Index Copernicus

  Clinical Cancer Investigation Journal

Clinical Cancer Investigation Journal, a publication of Middle-Eastern Association for Cancer Research (MEACR), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published.

More about the journal >>

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online